Abstract
Objectives: The study was designed to an estimate the prevalence of antiphospholipid IgG and IgM antibodies with toxoplasmosis patients among aborted and non-aborted women. Methodology: A total number of 70 Iraqi patients aborted and non-aborted women were included in the present study. In addition, a total of 30 apparently healthy women and negative for antiphospholipid IgG and IgM antibodies were selected as a control group. The study was carried out during the period of October 2012 till January 2013. Blood samples and laboratory investigation was in Teaching Laboratory of the Medical city of Baghdad, using to detect antibodies type IgG and IgM for antiphospholipid and Toxoplasma gondii by utilize ELISA technique according to standard procedures describe by manufacturer. Results: The results showed that the age stratum (21-30) years was found to be highly frequent in both studiedgroups was significant (P<0.05). In addition, positive toxoplasmosis IgG antibodies testing in aborted women was higher than that observed in non - aborted women group, significant (P < 0.05). Present study illustrated that the total abortion cases was with positive in APL-IgM-Ab 12/58 (20.7%), whereas 46/58 (79.3%) was negative the statistical analysis were high significant. The results of our study demonstrate significant positive correlation between abortion toxoplasmosis IgG and IgM . Conclusion: The present study demonstrates a strong association between infectious agent Toxoplasma gondii andabortion in women with anti-phospholipids antibodies. Positive toxoplasmosis IgM and IgG antibodies testing inabortion more than non-abortion. The frequency of anti-phospholipids antibodies IgM and IgG positive in abortionmore than non- abortion. Recommendation: cannot be according to the antiphospholipid antibodies IgG and IgM in abortion cases. So thatfurther studies are needed to study the relationship between rubella virus and cytomegalovirus with anti-phospholipid antibodies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
